- Phare
 - Validé par KD/KO
 
Anticorps Polyclonal de lapin anti-CDCA2
CDCA2 Polyclonal Antibody for WB, IF/ICC, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
WB, IHC, IF/ICC, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 17701-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules Jurkat, cellules HepG2, cellules MCF-7 | 
| Résultats positifs en IP | cellules Jurkat | 
| Résultats positifs en IF/ICC | cellules HepG2, | 
Dilution recommandée
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 | 
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate | 
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 2 publications below | 
| WB | See 6 publications below | 
| IHC | See 1 publications below | 
| IF | See 2 publications below | 
| IP | See 1 publications below | 
Informations sur le produit
17701-1-AP cible CDCA2 dans les applications de WB, IHC, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain | 
| Réactivité citée | Humain | 
| Hôte / Isotype | Lapin / IgG | 
| Clonalité | Polyclonal | 
| Type | Anticorps | 
| Immunogène | CDCA2 Protéine recombinante Ag11967 | 
| Nom complet | cell division cycle associated 2 | 
| Masse moléculaire calculée | 113 kDa | 
| Poids moléculaire observé | 125 kDa | 
| Numéro d’acquisition GenBank | BC036214 | 
| Symbole du gène | CDCA2 | 
| Identification du gène (NCBI) | 157313 | 
| Conjugaison | Non conjugué | 
| Forme | Liquide | 
| Méthode de purification | Purification par affinité contre l'antigène | 
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol | 
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. | 
Informations générales
Cell division cycle associated 2(CDCA2) is a nuclear protein that is a specific regulatory subunit for protein phosphatase 1γ (PP1γ). CDCA2 is a candidate factor involved in preparing mitotic chromatin for the transition to interphase, and controls PP1γ-dependent essential DDR regulationCDCA2 regulates the DNA damage response(DDR) in cell cycle. In addition, CDCA2 modulates phosphorylation of major mitotic histone H3 in a PP1-dependent manner. We got 125 kDa in western blotting maybe due to its phosphorylation.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for CDCA2 antibody 17701-1-AP | Download protocol | 
| IF protocol for CDCA2 antibody 17701-1-AP | Download protocol | 
| IP protocol for CDCA2 antibody 17701-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
Oncogene CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
  | ||
Oncogene MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors. | ||
Sci Rep Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin. | ||
J Cell Sci SUMOylation of RepoMan during late telophase regulates dephosphorylation of lamin A.
  | ||
Cell Biosci PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer progression | ||
Cell Signal Integration analysis of cell division cycle-associated family genes revealed potential mechanisms of gliomagenesis and constructed an artificial intelligence-driven prognostic signature | 




